|
| |
Amyotrophic Lateral SclerosisDownload PDF containing detailed information.
Recent Publications on Amyotrophic Lateral Sclerosis: |  |
The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALS.
Background and purpose: Mutations in fused in sarcoma (FUS) were recently... | 20th November, 2009
| Department of Neurology, K.U. Leuven, Leuven, Belgium.
| Eur J Neurol. 2009 Nov 13.
DOI Direct Link |
CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
Hypocretin (orexin) neurotransmission is not only crucially involved in... | 20th November, 2009
| Radboud University Nijmegen, Donders Centre for Neuroscience, Medical
| Amyotroph Lateral Scler. 2009;10(5-6):487-489.
|
Two consecutive pregnancies in early and late stage of amyotrophic lateral sclerosis.
There are few reports on pregnancies in sporadic and familial amyotrophic... | 20th November, 2009
| Clinic of General Neurology, Medical University Sofia, University Hospital
| Amyotroph Lateral Scler. 2009;10(5-6):483-486.
|
SOD1 G93D mutation presenting as paucisymptomatic amyotrophic lateral sclerosis.
We describe a patient with a familial form of amyotrophic lateral... | 20th November, 2009
| Istituto di Neurologia.
| Amyotroph Lateral Scler. 2009;10(5-6):479-482.
|
Familial ALS with SOD1 mutation misdiagnosed with polyradiculopathy and myopathy.
We report a 54-year-old male with progressive and asymmetrical lower... | 20th November, 2009
| Neuromuscular Center, Neurological Institute, Cleveland Clinic,
| Amyotroph Lateral Scler. 2009;10(5-6):476-478.
|
→View more research publications. |
Press Releases About Amyotrophic Lateral Sclerosis:
|
 |
| NuVasive Announces Conference Call and Webcast Regarding Reimbursement |
25th November, 2009 |
NuVasive, Inc. |
SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine,
|
| Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger |
24th November, 2009 |
Hard to Treat Diseases |
BELGRADE, Serbia, Nov. 24 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, is providing this brief update to its
|
| NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference |
23rd November, 2009 |
NuVasive, Inc. |
SAN DIEGO, Nov. 23 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine,
|
| Hard To Treat Diseases (HTDS) Appoints Fred Carlini as Strategic Advisor |
23rd November, 2009 |
Hard to Treat Diseases |
Former Head of Worldwide Development for Roche Labs To Advise HTDS
SHENZHEN, China, Nov. 23 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com Hard to Treat Diseases, Inc. (HTDS) announced appointment
|
| You Can Tell a Bug by Its Cover! |
18th November, 2009 |
Olympus America Inc. |
CENTER VALLEY, Pa., Nov. 18 /PRNewswire/ -- A glowing, eerily beautiful image of a water flea with its radiant green "crown of thorns" took top prize in the 2009 Olympus BioScapes Digital
|
Companies working in the area of Amyotrophic Lateral Sclerosis from Bioportfolio's Biocorporate database : | |
| Company Name | |
The Aggregated Misfolded Protein diseases include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease ...
www.amorfix.com/ View full profile
| |
Axaron Bioscience AG is a biotech company that aims to develop drugs which address the large-volume and fast growing neurodegenerative disorders market. The company has built an attractive portfolio...
www.axaron.com/ View full profile
| |
BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult...
www.brainstorm-cell.com View full profile
| | →View more Amyotrophic Lateral Sclerosis related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for Amyotrophic Lateral Sclerosis scientists - we have details of around 1011 individuals working on Amyotrophic Lateral Sclerosis .
This page has been viewed 444 times
Recent Search Terms used to find this page: brainstorm almyotrophic | amyotrophic lateral sclerosis PHARMACEUTICAL RESEARCH IN 2009 | stem cell in treatment amytrophic sclerosis .pdf | esclerosis lateral iplex 2009 | Stem cells comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery | Stem cells comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery | A case study of an emerging visual artist with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. | Amyotrophic Lateral Sclerosis news 2009 | Stem cells comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Amyotrophic Lateral Sclerosis across BioPortfolio, or for Amyotrophic Lateral Sclerosis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
